Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorder in Complete Remission in Response to Treatment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02959385
What this trial is testing

A Phase II Trial to Compare Efficacy and Safety of CRT VS Neo-CRT in Patients Who Achieved CCR for Esophageal Cancer

Who this might be right for
Stage II Esophageal CancerStage III Esophageal Cancer
Tianjin Medical University Cancer Institute and Hospital 40
Testing effectiveness (Phase 2)Looking for participantsNCT06238648
What this trial is testing

Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy

Who this might be right for
Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedPrimary Mediastinal Large B-Cell LymphomaTransformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma
Academic and Community Cancer Research United 120
Not applicableLooking for participantsNCT04055220
What this trial is testing

Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas

Who this might be right for
Bone SarcomaOsteosarcomaEwing Sarcoma+4 more
Centre Leon Berard 168
Large-scale testing (Phase 3)UnknownNCT02879513
What this trial is testing

Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Response to Neoadjuvant Chemotherapy

Who this might be right for
Invasive Ductal Breast CancerTubular Breast CancerMucinous Breast Cancer+1 more
RenJi Hospital 290
Not applicableLooking for participantsNCT07829848
What this trial is testing

Response-Adapted Omission of Nodal Boost In N3 Breast Cancer After Neoadjuvant Systemic Therapy

Who this might be right for
Breast Cancer
Fudan University 534
Post-approval studies (Phase 4)Study completedNCT00219310
What this trial is testing

RELIEF: Randomized Episodic Versus Long-Term Suppression Experience With Famciclovir

Who this might be right for
Recurrent Genital Herpes (RGH)
Novartis
Testing effectiveness (Phase 2)Looking for participantsNCT06831955
What this trial is testing

LifEStyle Intervention to Enhance Efficacy of Neoadjuvant Therapy in Patients With Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer (TNBC), Early Setting
Universitaire Ziekenhuizen KU Leuven 356
Testing effectiveness (Phase 2)Looking for participantsNCT06939127
What this trial is testing

Cryoablation Combined With Tislelizumab and Chemotherapy as Neoadjuvant and Adjuvant Therapy in Resectable Stage II-IIIB NSCLC

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)
Tianjin Medical University Cancer Institute and Hospital 38
Large-scale testing (Phase 3)UnknownNCT03708042
What this trial is testing

Compare Efficacy and Safety of DRT VS CRT Plus Surgery in Patients Who Achieved CCR for Esophageal Cancer

Who this might be right for
Stage II Esophageal CancerStage III Esophageal Cancer
Tianjin Medical University Cancer Institute and Hospital 220
Not applicableNot Yet RecruitingNCT07573397
What this trial is testing

A Prospective Study of Tumor-specific Tpex in Negative Lymph Nodes for Predicting Pathological Complete Response to Neoadjuvant PD 1 Therapy in Esophageal Cancer

Who this might be right for
Esophageal Cancer
Fudan University 88
Not applicableUnknownNCT01612247
What this trial is testing

Low Dose Chemotherapy With Aspirin in Patients With Breast Cancer After Neoadjuvant Chemotherapy

Who this might be right for
Breast Cancer
University of Vermont 13
Not applicableUnknownNCT05684874
What this trial is testing

Multiparametric Quantitative MRI and Response to Neoadjuvant Radiotherapy for Soft-tissue Sarcoma

Who this might be right for
Soft Tissue SarcomaAdult Soft Tissue SarcomaResectable Soft Tissue Sarcoma
Centre Leon Berard 25
Large-scale testing (Phase 3)Ended earlyNCT04269395
What this trial is testing

Assess Recurrence of Actinic Keratosis in Participants Treated With Methyl Aminolevulinate Hydrochloride Cream or Vehicle Cream Who Achieved Complete Response to Treated Lesions in Earlier Study

Who this might be right for
Keratosis, Actinic
Galderma R&D 125
Early research (Phase 1)Study completedNCT01051063
What this trial is testing

Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy

Who this might be right for
Leukaemia, Myelocytic, Acute
GlaxoSmithKline 17
Post-approval studies (Phase 4)Active Not RecruitingNCT04928261
What this trial is testing

Evaluating 6-months of HER2-targeted Therapy in Patients With HER2 Positive Early-stage Breast Cancer That Achieve a Pathological Complete Response to Neoadjuvant Systemic Therapy

Who this might be right for
Breast Cancer
Ottawa Hospital Research Institute 52
Not applicableWithdrawnNCT07805538
What this trial is testing

Response-Adapted Omission of Nodal Boost In N3 Breast Cancer After Neoadjuvant Therapy

Who this might be right for
Breast Cancer
Fudan University
Testing effectiveness (Phase 2)Active Not RecruitingNCT01937117
What this trial is testing

Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 88
Not applicableApproved For MarketingNCT03079687
What this trial is testing

Expanded Access Program for Olaparib Tablets as Maintenance Therapy in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Who this might be right for
Ovarian Cancer
AstraZeneca
Testing effectiveness (Phase 2)Study completedNCT00250042
What this trial is testing

A Phase II Study of Gleevec and Arsenic Trioxide in Patients With CML Who Fail Gleevec

Who this might be right for
Leukemia, OtherCancer
New Mexico Cancer Research Alliance 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT02971748
What this trial is testing

Pembrolizumab in Treating Patients With Hormone Receptor Positive, Localized Inflammatory Breast Cancer Who Are Receiving Hormone Therapy and Did Not Achieve a Pathological Complete Response to Chemotherapy

Who this might be right for
Anatomic Stage IIIB Breast Cancer AJCC v8Anatomic Stage IIIC Breast Cancer AJCC v8Breast Inflammatory Carcinoma+2 more
M.D. Anderson Cancer Center 36
Next Page